Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD).

52W Range

78thpctl

Volume

0.42×avg

Market Cap

961.85MUSD

P/E Ratio

-5.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Solid Biosciences Inc.

SLDBNASDAQ Global Select·USD·Closed

Solid Biosciences Inc.

SLDBNASDAQ·USD·Closed

$9.77

−3.55%

$9.77

−$0.36 (3.55%)

52W Range

78thpctl

Volume

0.42×avg

Mkt Cap

961.85MUSD

P/E

-5.1TTM

Div Yield

–ann

SLDB: Solid Biosciences Inc. Stock Analysis | finqOS